Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial.
第一作者:
K,Alexopoulos
第一单位:
Department of Medical Oncology, Evagelismos General Hospital, Athens, Greece.
作者:
医学主题词
成年人(Adult);老年人(Aged);抗肿瘤药(Antineoplastic Agents);抗肿瘤药, 植物(Antineoplastic Agents, Phytogenic);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);顺铂(Cisplatin);剂量效应关系, 药物(Dose-Response Relationship, Drug);药物疗法, 联合(Drug Therapy, Combination);女(雌)性(Female);粒细胞集落刺激因子(Granulocyte Colony-Stimulating Factor);人类(Humans);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);紫杉酚(Paclitaxel);重组蛋白质类(Recombinant Proteins);存活率分析(Survival Analysis);紫杉烷类(Taxoids)
DOI
10.1007/s002800050892
PMID
9923557
发布时间
2018-12-01
- 浏览112
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



